Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: A population-based study
Open accessAbstract
Patients with multiple myeloma (MM) have an increased risk of venous thrombosis. Interestingly, excess risk of venous thromboembolism has been observed among patients with monoclonal gammopathy of undetermined significance (MGUS). Using population-based data from Sweden, we assessed the risks of venous and arterial thrombosis in 18,627 MM and 5326 MGUS patients diagnosed from 1958 to 2006, compared with 70,991 and 20,161 matched controls, respectively. At 1, 5, and 10 years after MM diagnosis, there was an increased risk of venous thrombosis: hazard ratios (95% confidence intervals) were 7.5 (6.4-8.9), 4.6 (4.1-5.1), and 4.1 (3.8-4.5), respectively. The corresponding results for arterial thrombosis were 1.9 (1.8-2.1), 1.5 (1.4-1.6), and 1.5 (1.4-1.5). At 1, 5, and 10 years after MGUS diagnosis, hazard ratios were 3.4 (2.5-4.6), 2.1 (1.7-2.5), and 2.1 (1.8-2.4) for venous thrombosis. The corresponding risks for arterial thrombosis were 1.7 (1.5-1.9), 1.3 (1.2-1.4), and 1.3 (1.3-1.4). IgG/IgA (but not IgM) MGUS patients had increased risks for venous and arterial thrombosis. Risks for thrombosis did not vary by M-protein concentration (> 10.0 g/L or < 10.0 g/L) at diagnosis. MGUS patients with (vs without) thrombosis had no excess risk of MM or Waldenström macroglobulinemia. Our findings are of relevance for future studies and for improvement of thrombosis prophylaxis strategies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is an increased incidence of venous thromboembolism compared to the general population in MM.
“There is also an increased incidence of venous thromboembolism compared to the general population [57].”
From Epidemiology, Staging, and Management of Multiple Myeloma (2021) · cites this paper as [57]
Cites
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575 · see citing works
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O’Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,172 · see citing works
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dimopoulos, M., Spencer, A., Attal, M., Prince, H. M., Harousseau, J.-L., Dmoszynska, A., Miguel, J. S., Hellmann, A., Facon, T., Foà, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070594 · Cited by 1,450 · see citing works
Facon, T. T. F., Mary, J., Hulin, C., Benboubker, L., Attal, M., Pegourié, B., Renaud, M., Harousseau, J. L., Guillerm, G., Chaleteix, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61537-2 · Cited by 865 · see citing works
Palumbo, A., Bringhen, S., Caravita, T., Merla, E., Capparella, V., Callea, V., Cangialosi, C., Grasso, M., Rossini, F., Galli, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68338-4 · Cited by 806 · see citing works
Richardson, P. G., Schlossman, R. L., Weller, E., Hideshima, T., Mitsiades, C., Davies, F., LeBlanc, R., Catley, L. P., Doss, D., Kelly, K., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0996 · Cited by 804 · see citing works
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
Rajkumar, S. V., Hayman, S. R., Lacy, M. Q., Dispenzieri, A., Geyer, S. M., Kabat, B., Zeldenrust, S. R., Kumar, S., Greipp, P. R., Fonseca, R., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2817 · Cited by 648 · see citing works
Barlogie, B., Desikan, R. K., Eddlemon, P., Spencer, T., Zeldis, J. B., Munshi, N. C., Badros, A. Z., Zangari, M., Anaissie, E. J., Epstein, J., et al. (2001) · Blood · doi:10.1182/blood.v98.2.492 · Cited by 539 · see citing works
Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma
Rajkumar, S. V., Hayman, S., Gertz, M. A., Dispenzieri, A., Lacy, M. Q., Greipp, P. R., Geyer, S., Iturria, N., Fonseca, R., Lust, J. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.116 · Cited by 512 · see citing works
Zangari, M., Anaissie, E. J., Barlogie, B., Badros, A. Z., Desikan, R. K., Gopal, A. V., Morris, C., Toor, A. A., Siegel, E. R., Fink, L. M., et al. (2001) · Blood · doi:10.1182/blood.v98.5.1614 · Cited by 490 · see citing works
Venous thromboembolism: disease burden, outcomes and risk factors
Heit, J. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01415.x · Cited by 448 · see citing works
Hazard Rate Estimation under Random Censoring with Varying Kernels and Bandwidths
Müller, H., & Wang, J. (1994) · Biometrics · doi:10.2307/2533197 · Cited by 341 · see citing works
Kristinsson, S. Y., Landgren, O., Dickman, P. W., Derolf, Å. R., & Björkholm, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0100 · Cited by 319 · see citing works
Self-citationZangari, M., Siegel, E. R., Barlogie, B., Anaissie, E. J., Saghafifar, F., Fassas, A., Morris, C., Fink, L. M., & Tricot, G. J. K. (2002) · Blood · doi:10.1182/blood-2002-01-0335 · Cited by 261 · see citing works
Lenalidomide and Venous Thrombosis in Multiple Myeloma
Knight, R., DeLap, R. J., & Zeldis, J. B. (2006) · New England Journal of Medicine · doi:10.1056/nejmc053530 · Cited by 234 · see citing works
Deep Venous Thrombosis and Thalidomide Therapy for Multiple Myeloma
Osman, K., Comenzo, R. L., & Rajkumar, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442516 · Cited by 228 · see citing works
Baz, R., Li, L., Kottke‐Marchant, K., Srkalović, G., McGowan, B. R., Yiannaki, E. O., Karam, M. A., Faiman, B. M., Jawde, R. M. A., Andresen, S. W., et al. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.12.1568 · Cited by 228 · see citing works
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Kristinsson, S. Y., Fears, T. R., Gridley, G., Turesson, I., Mellqvist, U., Björkholm, M., & Landgren, O. (2008) · Blood · doi:10.1182/blood-2008-04-151076 · Cited by 198 · see citing works
Self-citationSrkalović, G., Cameron, M. G., Rybicki, L. A., Deitcher, S. R., Kattke‐Marchant, K., & Hussein, M. A. (2004) · Cancer · doi:10.1002/cncr.20405 · Cited by 172 · see citing works
Landgren, O., Kristinsson, S. Y., Goldin, L. R., Caporaso, N. E., Blimark, C. H., Mellqvist, U., Wåhlin, A., Björkholm, M., & Turesson, I. (2009) · Blood · doi:10.1182/blood-2008-12-191676 · Cited by 167 · see citing works
Self-citationKristinsson, S. Y., Björkholm, M., Goldin, L. R., McMaster, M. L., Turesson, I., & Landgren, O. (2008) · Blood · doi:10.1182/blood-2008-06-162768 · Cited by 163 · see citing works
Self-citationCavo, M., Zamagni, E., Cellini, C., Tosi, P., Cangini, D., Cini, M., Valdré, L., Palareti, G., Masini, L., Tura, S., et al. (2002) · Blood · doi:10.1182/blood-2002-06-1674 · Cited by 152 · see citing works
Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer
Bennett, C. L., Angelotta, C., Yarnold, P. R., Evens, A. M., Zonder, J. A., Raisch, D. W., & Richardson, P. G. G. (2006) · JAMA · doi:10.1001/jama.296.21.2558-c · Cited by 149 · see citing works
Thalidomide and rituximab in Waldenstrom macroglobulinemia
Treon, S. P., Soumerai, J. D., Branagan, A. R., Hunter, Z. R., Patterson, C. J., Ioakimidis, L., Briccetti, F., Pasmantier, M. W., Zimbler, H., Cooper, R. B., et al. (2008) · Blood · doi:10.1182/blood-2008-04-150854 · Cited by 142 · see citing works
Zonder, J. A., Barlogie, B., Durie, B. G. M., McCoy, J., Crowley, J. J., & Hussein, M. A. (2006) · Blood · doi:10.1182/blood-2006-01-0154 · Cited by 138 · see citing works
Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia
Treon, S. P., Soumerai, J. D., Branagan, A. R., Hunter, Z. R., Patterson, C. J., Ioakimidis, L., Chu, L., Musto, P., Baron, A. D., Nunnink, J. C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0862 · Cited by 128 · see citing works
Treatment of Waldenstrom’s Macroglobulinemia With Thalidomide
Dimopoulos, M. A., Zomas, A., Viniou, N. A., Grigoraki, V., Galani, E. P., Matsouka, C., Economou, O., Anagnostopoulos, N. I., & Panayiotidis, P. G. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3596 · Cited by 127 · see citing works
Turesson, I., Linet, M. S., Björkholm, M., Kristinsson, S. Y., Goldin, L. R., Caporaso, N. E., & Landgren, O. (2007) · International Journal of Cancer · doi:10.1002/ijc.22912 · Cited by 124 · see citing works
Self-citationKristinsson, S. Y., Björkholm, M., Andersson, T., Eloranta, S., Dickman, P. W., Goldin, L. R., Blimark, C. H., Mellqvist, U., Wåhlin, A., Turesson, I., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010066 · Cited by 112 · see citing works
Self-citationSallah, S., Husain, A., Wan, J. Y., Vos, P. W., & Nguyen, N. P. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh385 · Cited by 84 · see citing works
Hussein, M. A. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-02-0080 · Cited by 69 · see citing works
Thromboembolic events during treatment with thalidomide
Urbauer, E., Kaufmann, H., Nösslinger, T., Raderer, M., & Drach, J. W. (2002) · Blood · doi:10.1182/blood-2001-12-0245 · Cited by 68 · see citing works
Zangari, M., Tricot, G. J. K., Polavaram, L., Zhan, F., Finlayson, A., Knight, R., Fu, T., Weber, D., Dimopoulos, M. A., Niesvizky, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0169 · Cited by 58 · see citing works
Thromboembolic Complications in Myelomatosis
Catovsky, D., IKOKU, N. B. I., Pitney, W. R., & Galton, D. A. G. (1970) · BMJ · doi:10.1136/bmj.3.5720.438 · Cited by 50 · see citing works
Arterial thrombosis in four patients treated with thalidomide
Scarpace, S., Hahn, T., Roy, H., Brown, K., Paplham, P., Chanan-Khan, A., van Besien, K., & McCarthy, Jr. (2005) · Leukemia & Lymphoma · doi:10.1080/10428190400015675 · Cited by 50 · see citing works
Prothrombotic Coagulation Abnormalities in Patients with Paraprotein-Producing B-Cell Disorders
Auwerda, J. J. A., Sonneveld, P., de Maat, M. P. M., & Leebeek, F. W. G. (2007) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2007.n.027 · Cited by 41 · see citing works
Thromboembolism in Patients on Thalidomide for Myeloma
Bowcock, S. J., Rassam, S. M. B., Ward, S. M., Turner, J. T., & Laffan, M. (2002) · Hematology · doi:10.1080/10245330290020126 · Cited by 40 · see citing works
Cohen, A. L., & Sarid, R. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.01.004 · Cited by 26 · see citing works
Arterial thrombosis and thalidomide
Göz, M., Eren, M., & Cakir, O. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0057-1 · Cited by 22 · see citing works
Arterial and Venous Thrombotic Complications with Thalidomide in Multiple Myeloma
Alkindi, S. S. A., Dennison, D., & Pathare, A. V. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.08.005 · Cited by 21 · see citing works
Thalidomide causes platelet activation, which can be abrogated by aspirin
Dunkley, S. M., & Gaudry, L. E. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02542.x · Cited by 19 · see citing works
Stroke in a Multiple Myeloma Patient Treated With Thalidomide
Ortı́n, X., Rodríguez‐Luaces, M., Calabuig, M., & Font, L. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.06.005 · Cited by 14 · see citing works
Thalidomide-associated Arterial Thrombosis: Two Case Reports
Altıntaş, A., Ayyildiz, O. M., Atay, A. E., Çil, T., Işıkdoğan, A., & Müftüoğlu, E. (2007) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v36n4p304 · Cited by 13 · see citing works
Kristinsson, S. Y., Björkholm, M., Goldin, L. R., Blimark, C. H., Mellqvist, U., Wåhlin, A., Turesson, I., & Landgren, O. (2008) · Blood · doi:10.1182/blood.v112.11.1678.1678 · Cited by 2 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology, Staging, and Management of Multiple Myeloma
Padala, S. A., Barsouk, A., Barsouk, A., Rawla, P., Vakiti, A., Kolhe, R., Kota, V., & Ajebo, G. H. (2021) · Medical Sciences · doi:10.3390/medsci9010003 · Cited by 332 · see citing works
“thromboembolism compared to the general population [57].”
Larocca, A., Cavallo, F., Bringhen, S., Raimondo, F. D., Falanga, A., Evangelista, A., Cavalli, M. M., Stanevsky, A., Corradini, P., Pezzatti, S., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344333 · Cited by 289 · see citing works
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience
Holstein, S. A., & McCarthy, P. L. (2017) · Drugs · doi:10.1007/s40265-017-0689-1 · Cited by 258 · see citing works
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Callander, N. S., Baljević, M., Adekola, K., Anderson, L. D., Campagnaro, E. L., Castillo, J. J., Costello, C. L., Devarakonda, S. S., Elsedawy, N., Faiman, M., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0002 · Cited by 210 · see citing works
Venous and Arterial Thromboembolism in Patients With Cancer
Gervaso, L., Dave, H. M., & Khorana, A. A. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.03.001 · Cited by 181 · see citing works
Sanfilippo, K. M., Luo, S., Wang, T., Fiala, M. A., Schoen, M. W., Wildes, T. M., Mikhael, J. R., Kuderer, N. M., Calverley, D. C., Keller, J., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25603 · Cited by 177 · see citing works
van de Donk, N. W. C. J., Palumbo, A. P., Johnsen, H. E., Engelhardt, M. M., Gay, F., Gregersen, H., Hájek, R., Kleber, M., Ludwig, H., Morgan, G. J., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.100552 · Cited by 175 · see citing works
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
Kristinsson, S. Y., Tang, M., Pfeiffer, R. M., Björkholm, M., Goldin, L. R., Blimark, C. H., Mellqvist, U. H., Wåhlin, A., Turesson, I., & Landgren, O. (2011) · Haematologica · doi:10.3324/haematol.2011.054015 · Cited by 146 · see citing works
Self-citationHow I manage monoclonal gammopathy of undetermined significance
Go, R. S., & Rajkumar, S. V. (2017) · Blood · doi:10.1182/blood-2017-09-807560 · Cited by 141 · see citing works
Thrombosis in Multiple Myeloma
Kristinsson, S. Y. (2010) · Hematology · doi:10.1182/asheducation-2010.1.437 · Cited by 117 · see citing works
Self-citationCancer associated thrombosis: risk factors and outcomes
Eichinger, S. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30092-5 · Cited by 110 · see citing works
Connolly, G. C., & Francis, C. W. (2013) · Hematology · doi:10.1182/asheducation-2013.1.684 · Cited by 109 · see citing works
Dunn‐Walters, D. K., & Ademokun, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.009 · Cited by 103 · see citing works
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies
Li, W., Garcia, D. A., Cornell, R. F., Gailani, D., Laubach, J. P., Maglio, M. E., Richardson, P. G. G., & Moslehi, J. J. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3350 · Cited by 102 · see citing works
Bradbury, C. A., Craig, Z., Cook, G., Pawlyn, C., Cairns, D. A., Hockaday, A., Paterson, A., Jenner, M. W., Jones, J. R., Drayson, M. T., et al. (2020) · Blood · doi:10.1182/blood.2020005125 · Cited by 96 · see citing works
Thrombosis is associated with inferior survival in multiple myeloma
Kristinsson, S. Y., Pfeiffer, R. M., Björkholm, M., Schulman, S., & Landgren, O. (2012) · Haematologica · doi:10.3324/haematol.2012.064444 · Cited by 90 · see citing works
Self-citationArterial Thrombosis in Patients with Cancer
Tuzovic, M., Herrmann, J., Iliescu, C., Marmagkiolis, K., Ziaeian, B., & Yang, E. H. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0635-x · Cited by 81 · see citing works
Libourel, E. J., Sonneveld, P., van der Holt, B., de Maat, M. P. M., & Leebeek, F. W. G. (2010) · Blood · doi:10.1182/blood-2009-12-257519 · Cited by 77 · see citing works
Risk of site-specific cancer in incident venous thromboembolism: A population-based study
Petterson, T. M., Marks, R. S., Ashrani, A. A., Bailey, K. R., & Heit, J. A. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.12.013 · Cited by 76 · see citing works
Kyle, R. A., & Rajkumar, S. V. (2011) · PubMed · Cited by 75 · see citing works
Approach to chemotherapy-associated thrombosis
Oppelt, P., Betbadal, A., & Nayak, L. V. (2015) · Vascular Medicine · doi:10.1177/1358863x14568705 · Cited by 74 · see citing works
Thrombosis and Hemostatic Abnormalities in Hematological Malignancies
Colombo, R., Gallipoli, P., & Castelli, R. (2014) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2014.05.003 · Cited by 71 · see citing works
Monoclonal gammopathy: The good, the bad and the ugly
Glavey, S. V., & Leung, N. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.12.001 · Cited by 66 · see citing works
Swan, D., Rocci, A., Bradbury, C. A., & Thachil, J. V. (2018) · British Journal of Haematology · doi:10.1111/bjh.15684 · Cited by 64 · see citing works
Treatment and disease‐related complications in multiple myeloma: Implications for survivorship
Chakraborty, R., & Majhail, N. S. (2020) · American Journal of Hematology · doi:10.1002/ajh.25764 · Cited by 62 · see citing works
Pegourié, B., Karlin, L., Benboubker, L., Orsini‐Piocelle, F., Tiab, M., Auger‐Quittet, S., Rodon, P., Royer, B., Leleu, X. P., Bareau, B., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25459 · Cited by 61 · see citing works
Cornell, R. F., Goldhaber, S. Z., Engelhardt, B. G., Moslehi, J. J., Jagasia, M., Harrell, S. L., Rubinstein, S. M., Hall, R. L., Wyatt, H., & Piazza, G. (2020) · British Journal of Haematology · doi:10.1111/bjh.16653 · Cited by 61 · see citing works
Gracheva, M. A., Urnova, E. S., Sinauridze, E. I., Tarandovskiy, I. D., Борисовна, О. Е., Полетаев, А. В., Mendeleeva, L. P., Иноятович, А. Ф., & Balandina, A. N. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1041385 · Cited by 60 · see citing works
Arterial thrombosis and cancer
Aronson, D., & Brenner, B. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.01.003 · Cited by 58 · see citing works
Multiple Myeloma Precursor Disease
Landgren, O., & Waxman, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1713 · Cited by 55 · see citing works
Self-citationAssessing the Risk and Prognosis of Thrombotic Complications in Cancer Patients
Kyriazi, V., & Theodoulou, E. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0490-ra · Cited by 54 · see citing works
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases
Hemminki, K., Försti, A., Houlston, R. S., & Sud, A. (2021) · International Journal of Cancer · doi:10.1002/ijc.33762 · Cited by 56 · see citing works
Sykes, D. B., O'Connell, C. L., & Schroyens, W. (2020) · Blood · doi:10.1182/blood.2019004216 · Cited by 54 · see citing works
Piedra, K. M., Peterson, T. J., Tan, C. R. C., Orozco, J., Hultcrantz, M. L., Hassoun, H., Mailankody, S., Lesokhin, A. M., Shah, U. A., Lu, S. X., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17772 · Cited by 53 · see citing works
Guidelines on the diagnosis and management of W aldenström macroglobulinaemia
Owen, R. G., Pratt, G., Auer, R. L., Flatley, R., Kyriakou, C. A., Lunn, M. P., Matthey, F., McCarthy, H. O., McNicholl, F. P., Rassam, S. M. B., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12760 · Cited by 52 · see citing works
Gregersen, H., Vangsted, A. J., Abildgaard, N., Andersen, N. F., Pedersen, R. S., Frølund, U. C., Helleberg, C., Broch, B., Pedersen, P. T., Gimsing, P., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1128 · Cited by 52 · see citing works
Adelborg, K., Corraini, P., Darvalics, B., Frederiksen, H., Ording, A. G., Horváth–Puhó, E., Rørth, M. R., & Sørensen, H. T. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14475 · Cited by 52 · see citing works
Alikhan, R., Gomez, K., Maraveyas, A., Noble, S., Young, A., Thomas, M. R., & the British Society for Haematology (2024) · British Journal of Haematology · doi:10.1111/bjh.19414 · Cited by 49 · see citing works
Thrombosis in multiple myeloma (MM)
Cesarman-Maus, G. N., Braggio, E., & Fonseca, R. (2012) · Hematology · doi:10.1179/102453312x13336169156933 · Cited by 51 · see citing works
Update of thrombosis in multiple myeloma
Leebeek, F. W. G. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30103-7 · Cited by 51 · see citing works
Sigurbergsdóttir, A. Ý., Rögnvaldsson, S., Þorsteinsdóttir, S., Sverrisdottir, I. S., Sigurðardóttir, G. Á., Viðarsson, B., Onundarson, P. T., Agnarsson, B. A., Sigurðardóttir, M. S., Þorsteinsdóttir, I., et al. (2023) · Haematologica · doi:10.3324/haematol.2023.283191 · Cited by 50 · see citing works
Self-citationMonoclonal gammopathy of thrombotic/thrombocytopenic significance
Kanack, A. J., Schaefer, J. K., Sridharan, M. R., Splinter, N. P., Kohlhagen, M., Singh, B., Lorenzo, S. B. D., Mauch, E. E., Hussein, M., Shaikh, M. E., et al. (2023) · Blood · doi:10.1182/blood.2022018797 · Cited by 48 · see citing works
Hematologic malignancies and thrombosis
Elice, F., & Rodeghiero, F. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.11.034 · Cited by 48 · see citing works
Chakraborty, R., Riaz, I. B., Malik, S. U., Marneni, N., Garcia, A. M., Anwer, F., Khorana, A. A., Rajkumar, S. V., Kumar, S. K., Murad, M. H., et al. (2020) · Cancer · doi:10.1002/cncr.32682 · Cited by 48 · see citing works
Venous thromboembolism in multiple myeloma is associated with increased mortality
Schoen, M. W., Carson, K. R., Luo, S., Gage, B. F., Li, A., Afzal, A., & Sanfilippo, K. M. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12411 · Cited by 47 · see citing works
Castillo, J. J. (2016) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.07.002 · Cited by 47 · see citing works
Comerford, C., Glavey, S. V., Quinn, J., & O’Sullivan, J. M. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15773 · Cited by 46 · see citing works
Antibodies and complement are key drivers of thrombosis
Stark, K., Kilani, B., Stockhausen, S., Busse, J., Schubert, I., Tran, T.-D., Gaertner, F., Leunig, A., Pekayvaz, K., Nicolai, L., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.007 · Cited by 47 · see citing works
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Lomas, O., Mouhieddine, T. H., Tahri, S., & Ghobrial, I. M. (2020) · Cancers · doi:10.3390/cancers12061554 · Cited by 45 · see citing works
Covut, F., Ahmed, R., Chawla, S., Ricaurte, F., Samaras, C. J., Anwer, F., Garcia, A., Angelini, D. E., Mazzoni, S. A., Faiman, B. M., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17505 · Cited by 44 · see citing works
Hjorth, M., Hjertner, Ø., Knudsen, L. M., Gulbrandsen, N., Holmberg, E. C., Pedersen, P. T., Andersen, N. F., Andréasson, B., Billström, R., Carlson, K. E., et al. (2012) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2012.01775.x · Cited by 44 · see citing works
Monoclonal Gammopathy of Undetermined Significance
Gonsalves, W. I., & Rajkumar, S. V. (2022) · Annals of Internal Medicine · doi:10.7326/aitc202212200 · Cited by 44 · see citing works
Nayak, L. V., Shi, H., Atkins, G. B., Lin, Z., Schmaier, A. H., & Jain, M. K. (2014) · Blood · doi:10.1182/blood-2014-01-547448 · Cited by 40 · see citing works
Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance
Liu, Y., & Parks, A. L. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.8124 · Cited by 38 · see citing works
Chakraborty, R., Rybicki, L. A., Wei, W., Valent, J. N., Faiman, B. M., Samaras, C. J., Anwer, F., & Khorana, A. A. (2022) · Blood · doi:10.1182/blood.2022015727 · Cited by 38 · see citing works
Annibali, O., Napolitano, M., Avvisati, G., & Siragusa, S. M. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.02.003 · Cited by 37 · see citing works
Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism
Gregersen, H., Nørgaard, M., Severinsen, M. T., Engebjerg, M. C., Jensen, P., & Sørensen, H. T. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01539.x · Cited by 36 · see citing works
Sanfilippo, K. M., Carson, K. R., Wang, T., Luo, S., Edwin, N. C., Kuderer, N. M., Keller, J., & Gage, B. F. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12634 · Cited by 33 · see citing works
Zà, T., Stefano, V. D., Rossi, E., Petrucci, M. T., Andriani, A., Annino, L., Cimino, G. G., Caravita, T., Pisani, F., Ciminello, A., et al. (2012) · British Journal of Haematology · doi:10.1111/bjh.12168 · Cited by 33 · see citing works
Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients
Leiba, M., Malkiel, S., Budnik, I., Rozic, G., Avigdor, A., Duek, A., Nagler, A., Kenet, G., & Livnat, T. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.03.010 · Cited by 32 · see citing works
What is the significance of monoclonal gammopathy of undetermined significance?
Atkin, C., Richter, A. G., & Sapey, E. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-5-391 · Cited by 32 · see citing works
Familial risks of unusual forms of venous thrombosis: a nationwide epidemiological study in Sweden
Zöller, B., Li, X., Sundquist, J., & Sundquist, K. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02326.x · Cited by 31 · see citing works
Landgren, O. (2010) · Hematology · doi:10.1182/asheducation-2010.1.295 · Cited by 30 · see citing works
Self-citationSpira, D., Weisel, K. C., Brodoefel, H., Schulze, M., Kaufmann, S., & Horger, M. (2011) · Academic Radiology · doi:10.1016/j.acra.2011.09.016 · Cited by 30 · see citing works
Global coagulation assays in hypercoagulable states
Lim, H. Y., Donnan, G. A., Nandurkar, H. H., & Ho, P. W. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-021-02621-1 · Cited by 29 · see citing works
Monoclonal Gammopathy of Thrombotic Significance
Gkalea, V., Fotiou, D., Dimopoulos, M. A., & Kastritis, E. (2023) · Cancers · doi:10.3390/cancers15020480 · Cited by 29 · see citing works
Patel, V. G., & Cornell, R. F. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0784-4 · Cited by 28 · see citing works
Crowley, M. P., Kevane, B., O’Shea, S. I., Quinn, S., Egan, K., Gilligan, O. M., & Áinle, F. N. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615625825 · Cited by 28 · see citing works
Update on Guidelines for the Prevention of Cancer-Associated Thrombosis
Elshoury, A., Schaefer, J. K., Lim, M. Y., Skalla, D. P., & Streiff, M. B. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.7108 · Cited by 27 · see citing works
Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma
Undas, A., Usnarska‐Zubkiewicz, L., Helbig, G., Woszczyk, D., Kozińska, J., Dmoszyńska, A., Podolak‐Dawidziak, M., & Kuliczkowski, K. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12269 · Cited by 26 · see citing works
Sborov, D. W., Baljević, M., Reeves, B., Laubach, J. P., Efebera, Y. A., Rodriguez, C., Costa, L. J., Chari, A., Silbermann, R. W., Holstein, S. A., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18432 · Cited by 25 · see citing works
Frenzel, L., Decaux, O., Macro, M., Belhadj‐Merzoug, K., Manier, S., Touzeau, C., Leleu, X. P., Frère, C., Lecompte, T., Perrot, A., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.11.021 · Cited by 27 · see citing works
Guo, L., Tong, D., Yu, M., Zhang, Y., Li, T., Wang, C., Zhou, P., Jin, J., Li, B., Liu, Y., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4354 · Cited by 25 · see citing works
IgG replacement in multiple myeloma
Wonnaparhown, A. M., Hilal, T., Squire, J. D., Freeman, C. M., & Fonseca, R. (2024) · Blood Cancer Journal · doi:10.1038/s41408-024-01107-6 · Cited by 24 · see citing works
Baseline and treatment-related changes in thrombin generation in patients with multiple myeloma
Tiong, I. S., Rodgers, S., Lee, C. H. S., & McRae, S. J. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1219900 · Cited by 24 · see citing works
Gade, I. L., Brækkan, S. K., Næss, I. A., Hansen, J.-B., Rosendaal, F. R., Cannegieter, S. C., Overvad, K., Jensvoll, H., Hammerstrøm, J., Gran, O. V., et al. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.09.002 · Cited by 24 · see citing works
Treliński, J., Misiewicz, M., Robak, M., Smolewski, P., & Chojnowski, K. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.01.011 · Cited by 24 · see citing works
Baker, H. A., Brown, A. R., Mahnken, J. D., Shireman, T. I., Webb, C., & Lipe, B. C. (2018) · Cancer Medicine · doi:10.1002/cam4.1927 · Cited by 23 · see citing works
Risk and management of thrombosis in multiple myeloma
Leebeek, F. W. G., Kruip, M. J. H. A., & Sonneveld, P. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70024-5 · Cited by 23 · see citing works
Acquired immune-mediated thrombophilia in lymphoproliferative disorders
Lechner, K., Simonitsch, I., Haselböck, J., Jaeger, U., & Pabinger, I. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.580474 · Cited by 22 · see citing works
Horváth–Puhó, E., Suttorp, M., Frederiksen, H., Hoekstra, T., Dekkers, O. M., Pedersen, L. H., Cannegieter, S. C., Dekker, F. W., & Sørensen, H. T. (2018) · Clinical Epidemiology · doi:10.2147/clep.s172306 · Cited by 21 · see citing works
Thrombosis and bleeding in hematological malignancy
Wang, T., Leader, A., & Sanfilippo, K. M. (2022) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2022.101353 · Cited by 21 · see citing works
Giannopoulos, K., Jamroziak, K., Usnarska‐Zubkiewicz, L., Dytfeld, D., Jurczyszyn, A. J., Walewski, J. A., Lech‐Marańda, E., Walter‐Croneck, A., Pieńkowska‐Grela, B., Wróbel, T., et al. (2018) · Acta Haematologica Polonica · doi:10.2478/ahp-2018-0024 · Cited by 21 · see citing works
Thrombosis in Lymphoma Patients and in Myeloma Patients
Yokoyama, K. (2015) · The Keio Journal of Medicine · doi:10.2302/kjm.2014-0017-re · Cited by 20 · see citing works
Unmet Needs in Managing Myocardial Infarction in Patients With Malignancy
Inohara, T., Endo, A., & Melloni, C. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00057 · Cited by 20 · see citing works
O'Sullivan, L. R., Meade-Murphy, G., Gilligan, O., Mykytiv, V., Young, P., & Cahill, M. (2020) · British Journal of Haematology · doi:10.1111/bjh.16774 · Cited by 22 · see citing works
Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study
Afzal, A., Fiala, M. A., Gage, B. F., Wildes, T. M., & Sanfilippo, K. M. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.07.003 · Cited by 19 · see citing works
Evolving data on cardiovascular complications in cancer
Willems, R. A. L., Winckers, K., Biesmans, C., de Vos‐Geelen, J., & Cate, H. T. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.01.003 · Cited by 19 · see citing works
Jiang, T., Su, H., Li, Y., Wu, Y., Ming, Y., Li, C., Fu, R., Feng, L., Li, Z., Li, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989032 · Cited by 19 · see citing works
Hultcrantz, M. L., Pfeiffer, R. M., Björkholm, M., Goldin, L. R., Turesson, I., Schulman, S., Landgren, O., & Kristinsson, S. Y. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12724 · Cited by 19 · see citing works
Self-citationThe independent association of mean platelet volume with overall survival in multiple myeloma
Zhuang, Q., Xiang, L., Xu, H., Fang, F., Xing, C., Liang, B., Yu, K., & Feng, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11551 · Cited by 19 · see citing works
Kirschner, M., Hartmann, N. D. Ó., Parmentier, S. B., Hart, C., Henze, L., Bisping, G., Grießhammer, M., Länger, F. P., Pabinger-Fasching, I., Matzdorff, A. C., et al. (2021) · Cancers · doi:10.3390/cancers13122905 · Cited by 18 · see citing works
Costa, T. A., Felix, N. S., Costa, B. A., Godoi, A., Nogueira, A., & Rossi, A. (2023) · British Journal of Haematology · doi:10.1111/bjh.19017 · Cited by 18 · see citing works
Li, X., Sundquist, J., Sundquist, K., & Zöller, B. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0655 · Cited by 18 · see citing works
Wang, J., Park, C., & Arroyo-Suárez, R. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1910687 · Cited by 18 · see citing works
Kristinsson, S. Y., Björkholm, M., Schulman, S., & Landgren, O. (2011) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.11.002 · Cited by 17 · see citing works
Self-citationManagement of the adverse effects of lenalidomide in multiple myeloma
González, A. P. (2011) · Advances in Therapy · doi:10.1007/s12325-010-0104-8 · Cited by 17 · see citing works
Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance
Schwartz, B., Schou, M., Ruberg, F. L., Rucker, D., Choi, J., Siddiqi, O. K., Monahan, K. M., Køber, L., Gislason, G., Torp-Pedersen, C. T., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.05.009 · Cited by 16 · see citing works
Thrombosis in multiple myeloma: mechanisms, risk assessment and management
Jarchowsky, O., Avnery, O. H., & Ellis, M. H. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2247513 · Cited by 16 · see citing works
Updates on thrombotic events associated with multiple myeloma
Fotiou, D., Gavriatopoulou, M., Ntanasis‐Stathopoulos, I., Migkou, M., Dimopoulos, M. A., & Terpos, E. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1604214 · Cited by 16 · see citing works
- Authors
- Kristinsson, S. Y., Pfeiffer, R. M., Björkholm, M., Goldin, L. R., Schulman, S., Blimark, C., Mellqvist, U.-H., Wahlin, A., Turesson, I., & Landgren, O.
- Affiliations
- Karolinska University Hospital (SE)
- National Institutes of Health (US)
- Sahlgrenska University Hospital (SE)
- Cancer Centre, Section of Hematology, Umea University Hospital, Umea, Sweden;
- Department of Medicine, Section of Hematology, Malmö University Hospital, Malmö, Sweden; and
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-06-17
- Volume
- 115
- Issue
- 24
- Pages
- 4991-4998
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2890150
- OpenAlex
- W1975136159
- Cited by
- 255
- References
- 44
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 21 · 2023: 25 · 2022: 19 · 2021: 17 · 2020: 20 · 2019: 14 · 2018: 11 · 2017: 10 · 2016: 19 · 2015: 10 · 2014: 15 · 2013: 9 · 2012: 13
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- monoclonal gammopathy of undetermined significance, multiple myeloma, venous thrombosis, arterial thrombosis, venous thromboembolism, Waldenström macroglobulinemia, thrombosis risk, thromboprophylaxis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Arteries, Female, Humans, Immunoglobulin A, Immunoglobulin G, Waldenstrom Macroglobulinemia, Male, Middle Aged, Multiple Myeloma, Paraproteinemias, Predictive Value of Tests, Registries, Risk Factors, Sweden, Veins, Proportional Hazards Models, Survival Analysis, Databases, Factual, Venous Thrombosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
